Feb 15 2019
ZURICH Danish logistics group DSV A/S sweetened its offer for Panalpina to $4.3 billion, with a tug of war escalating on Friday over the Swiss company as it weighs a separate deal with Kuwait's Agility Group.
Feb 13 2019
ZURICH Clariant missed fourth quarter profit and sales expectations on Wednesday due to softening demand in Asia and Europe, sending shares in the Swiss specialty chemicals maker lower.
Feb 11 2019
ZURICH Airopack's recapitalization plan collapsed as lenders including Apollo Global Management demanded repayment following the discovery of "inadequate sales and accounting practices", the Swiss aerosol packaging maker said on Monday.
Feb 07 2019
* CFO says J&J was fully aware of Actelion DOJ probe
(Adds details about possible deals, comments from CEO, CFO,
details about Actelion settlement)
Feb 07 2019
ZURICH Novartis AG Chief Executive Vas Narasimhan said his company's prescription drug prices have been "flat to negative" over the last three years, and directed blame for high costs for U.S. patients on industry middlemen that manage drug benefits.
Feb 06 2019
ZURICH Novartis AG Chief Executive Vas Narasimhan said his company's prescription drug prices have been "flat to negative" over the last three years, and directed blame for high costs for U.S. patients on industry middlemen that manage drug benefits.
Feb 06 2019
ZURICH, Feb 6 Novartis AG Chief
Executive Vas Narasimhan said his company's prescription drug
prices have been "flat to negative" over the last three years,
and directed blame for high costs for U.S. patients on industry
middlemen that manage drug benefits.
Feb 06 2019
Switzerland's Sunrise Communications Group has confirmed it is in talks over a potential acquisition of broadband provider Liberty Global's Swiss business UPC Schweiz.
Feb 05 2019
ZURICH Swiss drugmaker Roche aims to broaden the use of its Kadcyla breast cancer treatment as rivals crowd into the market with biosimilar copies of its older mainstay Herceptin.